In humans, mutations in the CaSR cause familial hypocalciuric hypercalcemia in heterozygotes and neonatal severe hyperparathyroidism in homozygotes, resulting in inappropriately normal or elevated PTH concentrations in the face of hypercalcemia (38). This evidence concerns the gene PTH and hyperparathyroidism.